Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 3,394 | 2,641 | 2,146 | 2,241 | 2,271 |
| Operating Income | -3,394 | -2,641 | -2,146 | -2,241 | -2,271 |
| Other Income | 27 | 27 | 198 | 42 | 45 |
| Pre-tax Income | -3,367 | -2,614 | -1,948 | -2,199 | -2,226 |
| Net Income Continuous | -3,367 | -2,614 | -1,948 | -2,199 | -2,226 |
| Net Income | $-3,367 | $-2,614 | $-1,948 | $-2,199 | $-2,226 |
| EPS Basic Total Ops | -0.78 | -0.49 | -0.48 | -0.51 | -0.48 |
| EPS Basic Continuous Ops | -0.78 | -0.49 | -0.48 | -0.51 | -0.48 |
| EPS Diluted Total Ops | -0.78 | -0.49 | -0.48 | -0.51 | -0.48 |
| EPS Diluted Continuous Ops | -0.78 | -0.49 | -0.48 | -0.51 | -0.48 |
| EBITDA(a) | $-3,370 | $-2,617 | $-2,123 | $-2,217 | $-2,249 |